Audited financial result for quarter and year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Checkpoint Trends Limited reported a sharp drop in full-year revenue to about ₹50.12 lakhs in FY25, down roughly 56% from ₹113.09 lakhs in FY24, driven by weaker net sales of ₹50 lakhs versus ₹113 lakhs last year. Profit after tax for the year stood at ₹2.54 lakhs (FY24: ₹3.02 lakhs), with basic EPS of ₹0.05. The Q4 standalone results showed revenue of ₹25 lakhs and a profit before tax of ₹7.02 lakhs, helped by a small negative exceptional item of ₹2.13 lakhs. The auditor (L K Ajmera & Associates) issued an unmodified/unqualified opinion on the results. The balance sheet remains weak with negative other equity of about ₹491 lakhs and no outstanding borrowings.
The steep revenue decline is a concern for this micro-cap company, even though the bottom line stayed marginally profitable and the auditor gave a clean report. Negative reserves highlight long-standing accumulated losses, which could limit future growth or raise capital concerns for shareholders.